Sumitomo Mitsui Trust Holdings Inc. 13D and 13G filings for Intellia Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-04 06:05 am Sale |
2021-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
Sumitomo Mitsui Trust Holdings Inc. | 2,753,903 3.700% |
-2,350,459 (-46.05%) |
Filing |
| 2021-02-05 06:10 am Sale |
2020-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
Sumitomo Mitsui Trust Holdings Inc. | 5,104,362 7.940% |
-318,856 (-5.88%) |
Filing |
| 2020-12-09 06:01 am Sale |
2020-11-30 | 13G | Intellia Therapeutics, Inc. NTLA |
Sumitomo Mitsui Trust Holdings Inc. | 5,423,218 9.180% |
-1,755,302 (-24.45%) |
Filing |